Stockholm (HedgeNordic) – A well-designed and experienced board of directors is a powerful tool for any firm, including an asset management business. Rhenman & Partners Asset Management (“Rhepa”) has strengthened its board of directors with the addition of Lars Wedenborn, who has been part of the Wallenberg sphere since 2000, as an independent board member.

“We are very pleased that Lars has accepted to join the Board of Rhenman & Partners,” comments Hans Wigzell, Chairman of the Board at Rhenman & Partners Asset Management. “With his long experience and broad expertise, Lars will be a great asset to the board and the firm. We warmly welcome him!”

“We are very pleased that Lars has accepted to join the Board of Rhenman & Partners.”

“I am very much looking forward to being a part of Rhenman & Partners’ journey forward. Our focus going forward is on developing the organization and ensuring that the fund can create good returns,” Lars Wedenborn comments on his new role. “Rhenman & Partners is a high-performing company with competent people with impressive excellence and a fast work pace,” Wedenborn describes his first impressions since taking on the role. “The scientific advisory board that supports the investment team is a great asset.”

“I am very much looking forward to being a part of Rhenman & Partners’ journey forward.”

Wedenborn has worked in the financial industry since the mid-1980s, including as the CFO of Alfred Berg between 1991 and 2000. In 2000, he joined what is commonly referred to as “the Wallenberg sphere,” which includes the Wallenberg Foundations, investment company Investor AB, and holding companies Wallengerg Investments and FAM AB. Wedenborn worked at Investor between 2000 and 2007, and later served as the CEO of FAM between 2007 and 2020. Owned by the three largerst Wallenberg Foundations, FAM is a privately-owned holding company focused on active ownership and long-term development of a number of strategic holdings such as SKF, Stora Enso, among others.

“Nowadays, I mainly have board assignments,” says Wedenborn. “I am currently chairman of the board of AMF and a member of Höganäs, tbd30, Rederi Gotland AB and since December 2022 also on the board of Rhenman & Partners.” Healthcare-focused asset manager Rhenman & Partners has successfully been running its healthcare-focused long-biased equity hedge fund, Rhenman Healthcare Equity L/S, since mid-2009. The fund’s main share class (IC1 EUR) has generated an annualized return of 16.4 percent since June 2009.

The Chairman position of Rhenman & Partners’ board is occupied by immunology and vaccines academic Professor Hans Wigzell, a former Nobel Prize committee chair and chief scientific adviser to the Government of Sweden. The board of directors also includes Birgitta Stymne Göransson and Henrik Rhenman, who runs the healthcare-focused long-biased equity fund alongside co-head and senior portfolio manager Susanna Urdmark and portfolio manager Kaspar Hållsten.